This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lloyd, K. O. Articles by DiBenedetto, C. Search for Related Content PubMed PubMed Citation Articles by Lloyd, K. O. Articles by DiBenedetto, C.

Cell Surface Accessibility of Individual Gangliosides in Malignant Melanoma Cells to Antibodies Is Influenced by the Total Ganglioside Composition of the Cells¹

Memorial Sloan-Kettering Cancer Center and Cornell University Graduate School of Medical Sciences, New York, New York 10021

The reactivity of a panel of antiganglioside monoclonal antibodies with a number of melanoma cell lines having different ganglioside composition profiles was studied. One cell line synthesized only GM3, one produced both GM3 and GD2, 2 had GM3 and GD3 as their major gangliosides, and 2 others synthesized approximately equal amounts of GM3, GM2, GD3, and GD2 gangliosides. Antibody reactivity with viable cells was analyzed by: (a) flow cytometry on suspension cells; and (b) mixed hemagglutination assays or immune adherence assays on monolayer cells in culture. GM3 was efficiently detected only in the cell line having GM3 as its sole ganglioside. In the other cell lines, GM3 was difficult to detect even in cells in which it made up a high proportion (up to 50%) of the total ganglioside content. GM2 was easily detectable only in JB-RH melanoma cells (which contain only GM3 and GM2). GD3 was the most reactive ganglioside in 2 cell lines and GD2 in 2 other lines. In general, the most complex ganglioside present in a cell was the one most accessible to antibody. The differential exposure at the cell surface of specific gangliosides may have implications for antibody-directed tumor detection and therapy and for cell-protein or cell-cell interactions that involve glycolipids.

¹ Supported by grants from the National Cancer Institute (CA 21445 and CA 08478).

² To whom requests for reprints should be addressed, at Memorial Sloan-Kettering, 1275 York Avenue, New York, NY 10021.

Received 1/28/92. Accepted 7/ 3/92.

This article has been cited by other articles:

				H. J. Willison, K. Townson, J. Veitch, J. Boffey, N. Isaacs, S. M. Andersen, P. Zhang, C.-C. Ling, and D. R. Bundle Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera Brain, March 1, 2004; 127(3): 680 - 691. [Abstract] [Full Text] [PDF]

				H. J. Willison and N. Yuki Peripheral neuropathies and anti-glycolipid antibodies Brain, December 1, 2002; 125(12): 2591 - 2625. [Abstract] [Full Text] [PDF]

				D. S. B. Hoon, C. T. Kuo, S. Wen, H. Wang, L. Metelitsa, C. P. Reynolds, and R. C. Seeger Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow Am. J. Pathol., August 1, 2001; 159(2): 493 - 500. [Abstract] [Full Text]

				N. Kovacic, J. Müthing, and A. Marusic Immunohistological and Flow Cytometric Analysis of Glycosphingolipid Expression in Mouse Lymphoid Tissues J. Histochem. Cytochem., December 1, 2000; 48(12): 1677 - 1690. [Abstract] [Full Text]

				C. W. Ang, B. C. Jacobs, A. H. Brandenburg, J. D. Laman, F. G. A. van der Meche, A. D. M. E. Osterhaus, and P. A. van Doorn Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome Neurology, April 11, 2000; 54(7): 1453 - 1458. [Abstract] [Full Text] [PDF]

				R. Chammas, J. L. Sonnenburg, N. E. Watson, T. Tai, M. G. Farquhar, N. M. Varki, and A. Varki De-N-acetyl-gangliosides in Humans: Unusual Subcellular Distribution of a Novel Tumor Antigen Cancer Res., March 1, 1999; 59(6): 1337 - 1346. [Abstract] [Full Text] [PDF]

				A. Schwarz and A. H. Futerman Determination of the Localization of Gangliosides Using Anti-ganglioside Antibodies: Comparison of Fixation Methods J. Histochem. Cytochem., April 1, 1997; 45(4): 611 - 618. [Abstract] [Full Text] [PDF]

				W.-X. Shi, R. Chammas, and A. Varki Regulation of Sialic Acid 9-O-Acetylation during the Growth and Differentiation of Murine Erythroleukemia Cells J. Biol. Chem., December 6, 1996; 271(49): 31517 - 31525. [Abstract] [Full Text] [PDF]